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Abstract (248/250 words)  
Objective: Increased weight gain surfaced as a problem after intensive treatment became the 
standard of care for youth with type 1 diabetes (T1D). In this study, we examined the current 
extent of the obesity problem in two large pediatric clinical registries in the US and Europe and 
examined the hypotheses that increased BMI z-scores would be associated with higher HbA1c 
and increased frequency of severe hypoglycemia (SH) in youth with T1D. 
Study Design: International (WHO) and national (CDC/KiGGS) BMI references were used to 
calculate BMI z-scores in participants (age 2-<18 years and ≥1 year duration of T1D) enrolled in 
the T1D Exchange (T1DX, n=11,435) and the Diabetes Prospective Follow-up (DPV, 
n=21,501). Associations between BMI z-scores and HbA1c and SH were assessed.   
Results: Participants in both registries had median BMI values that were greater than 
international and their respective national reference values. BMI z-score was significantly higher 
in the T1DX versus the DPV (p<0.001). After stratification by age-group, no differences in BMI 
between registries existed for children 2-5 years, but differences were confirmed for 6-9, 10-13 
and 14-17 year age-groups (all p<0.001). Higher BMI z-scores were significantly related to 
higher HbA1c levels and more frequent occurrence of SH across the registries, although these 
associations may not be clinically relevant.  
Conclusions: Excessive weight is a common problem in children with T1D in Germany and 
Austria and, especially, in the US. Our data suggest that obesity contributes to the challenges in 
achieving optimal glycemic control in children and adolescents with T1D.  
 
Page 4 of 23 
 
Introduction  
Historically, obesity was rare in people with type 1 diabetes (T1D) due to ineffective methods to 
achieve glucose control.  In 1993, the Diabetes Control and Complications Trial (DCCT) 
established the importance of intensive diabetes management in adults and adolescents with T1D 
(1, 2), but this therapy paradigm was accompanied by increased weight gain in intensively 
treated participants (3, 4).  In the follow up to the DCCT, the Epidemiology of Diabetes 
Interventions and Complications (EDIC) study, increased body mass index (BMI) was associated 
with increased cardiovascular disease risk factors and markers of atherosclerosis (coronary artery 
calcification and carotid intima media thickness) (5).  In a similar time period as the transition to 
intensive therapy for patients with T1D, Western countries have experienced an epidemic of 
pediatric obesity (6) and youth with T1D are unlikely to have been spared from these effects.  
Increased BMI in youth with T1D has been reported in clinic based and national cohorts (7-14) 
and is associated with a more atherogenic cardiovascular disease risk profile (11, 13, 15).   
Elevated BMI increases insulin resistance; however, the association of BMI, insulin resistance, 
HbA1c, SH, and daily insulin doses is complex.  International data comparing BMI in youth with 
T1D and the association of BMI with glucose control across countries does not exist.   
 
The T1D Exchange (T1DX) registry in the US and the Diabetes Prospective Follow-up (DPV) 
registry in Germany and Austria are two large consortia of pediatric diabetes centers that were 
established with an objective of improving the care of children with T1D through sharing of best 
practices and the collection of clinical outcome data in large numbers of patients.  In this 
collaborative study, both T1DX and DPV used queries of their databases to describe the 
prevalence of elevated BMI z-scores (BMIz) in youth with T1D who were 2 to <18 years of age 
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and had ≥1 year duration of diabetes.  In addition, we tested the hypothesis that increased BMIz 
was associated with poorer metabolic control (higher hemoglobin A1c [HbA1c] and increased 
frequency of severe hypoglycaemia [SH]) in both registries. 
 
Methods 
The T1DX Clinic Network includes 70 US based pediatric and adult endocrinology practices in 
34 states.  A registry of more than 26,000 individuals with T1D commenced enrollment in 
September 2010 (16).  Each clinic received approval from a local institutional review board 
(IRB). Informed consent was obtained according to IRB requirements.  Data were collected for 
the registry’s central database from the participant’s medical record and by having the participant 
or parent complete a comprehensive questionnaire, as previously described (16).  
 
The DPV registry is a prospective longitudinal, standardized, and computer-based documentation 
system for patients with all types of diabetes.  Currently, more than 90% of German and more 
than 70% of Austrian children with diabetes are included in the registry.  Data are documented 
locally by the 391 participating centers in an electronic health record.  Twice yearly, anonymized 
data are exported and transmitted for central analyses.  Missing and inconsistent data are 
reported back to the centers for correction.  Data collection is approved by the ethics committee 
at Ulm University and by the IRBs at the participating centers (17, 18).   
 
This report includes data on 32,936 children 2 to <18 years of age, with T1D duration of at least 
1 year and available height and weight data; 11,435 participants enrolled in the T1DX from 
September 2010 to August 2012 at 59 sites who care for pediatric patients and 21,501 patients 
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from 262 sites in the DPV who had at least one office visit in either 2011 or 2012.  All eligible 
T1DX and DPV participants were included in this analysis.  Median HbA1c over the year prior 
to the registry assessment, calculated from all available for the prior year but excluding any 
values obtained within 3 months of diagnosis, was used to represent HbA1c in this analysis.  For 
both the T1DX and DPV, all HbA1c values were DCCT-standardized (19, 20).  SH was defined 
by both registries as a hypoglycemic event in which seizure or loss of consciousness occurred.  
The numbers given correspond to the percent of patients with at least one SH event during the 
previous year.  BMI percentiles and z-scores were calculated from height and weight and 
adjusted for age and sex, using both international (WHO) and national (CDC for T1DX and 
KiGGS for DPV) reference tables (21-26).  Extreme BMIz values <-3 and >+3 were truncated.  
In the WHO and the national reference populations, a BMIz of 0 represents the mean value of the 
population; values above the mean are positive and values below the mean are negative.  BMI 
categories were defined using BMIz according to pediatric standards for each source (22, 26, 
27).  Underweight individuals were excluded from analyses assessing glucose control, as 
underweight status in adolescents with T1D is often due to eating disorders and psychiatric 
disorders have a strong impact on HbA1c and SH. 
 
In the T1DX, data were obtained through a combination of clinic and participant-report.  Method 
of insulin delivery (pump/injection), height, weight, HbA1c values, and frequency of SH were 
extracted from the medical chart.  Rates of self-monitoring of blood glucose and insulin dose 
were obtained from participant report via completion of a questionnaire.  Conversely, all data 
from the DPV was extracted from the electronic medical record, as documented by members of 
the local diabetes team during routine patient care. All data from T1DX were obtained at the 
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enrollment visit through retrospective chart review and data from DPV were collected from 
office visits that occurred during 2011 or 2012 (a similar time period as T1DX enrollment). 
 
Statistical Methods   
To compare BMI between the two registries, a mixed model was performed, using BMIz 
calculated from the WHO reference tables.  The model accounted for site differences and 
adjusted for T1D duration, sex, age group, and the interaction between registry and age group.  
Mixed models also were conducted to assess whether BMI was associated with HbA1c or SH, 
overall (WHO reference and adjusted for T1D duration, sex, age group, registry, and random site 
effect) and within each registry (CDC or KiGGS reference and adjusted for T1D duration, sex, 
age group, and random site effect).  Tests of significance were reported from models using BMIz 
as a continuous variable; adjusted means were reported from models using BMI as a categorical 
variable. Underweight individuals (based on corresponding cutoffs for underweight 
categorization) were excluded from these analyses.  While BMIz adjusts an individual BMI 
value for age and sex of the reference population, these factors were not fully adjusted for in our 
population, and thus were included in the statistical models to account for residual confounding 
that could be present in this analysis cohort.  All statistical analyses were performed using SAS 
9.4 (SAS Institute, Cary, NC).  All p values are two-sided.  A priori, in view of the large sample 
size and multiple comparisons, only p values <0.01 were considered statistically significant. 
 
Results 
Participant characteristics of children in the T1DX and DPV registries can be found in Table 1.  
Children in both registries were similar with respect to sex, total daily insulin dose per kg (TDI), 
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and frequency of SH, but a higher percentage of children in T1DX were using an insulin pump 
(56% vs 45%).  Children in T1DX also had a higher mean HbA1c level (8.5% vs 7.9%) than 
those in DPV.    
 
Children in both registries had elevated BMI compared to international reference values 
(unadjusted median BMIz 0.78 for T1DX and 0.65 for DPV) and their respective national 
reference values (unadjusted median BMIz 0.74 for T1DX and 0.33 for DPV) (Table 1).  
Overall, by the WHO, 12% (n=3,977) of children in both registries combined were considered 
obese, 24% (n=7,825) overweight, 64% (n=20,942) normal weight, and <1% (n=192) 
underweight (Table 2).  
 
When comparing BMIz between the registries using WHO reference tables, BMI was 
significantly higher in T1DX than in DPV (p<0.001, Table 1).  Differences in least squares mean 
BMIz by age group are shown in Figure 1, adjusted for T1D duration, sex, age group, and the 
interaction between registry and age group.  No significant difference in BMIz was found in the 
2 to <6 year old group (p=0.10), but children in T1DX had higher BMIz than DPV children in all 
other age groups (p<0.001 for all).  
 
Overall, higher BMIz (WHO) was associated with higher HbA1c, adjusted for T1D duration, 
sex, age group, and registry (Figure 2a, p<0.001).  When we looked at the registry-specific BMIz 
(CDC or KiGGS), higher BMI was also associated with higher HbA1c within each registry 
(p<0.001 for both, adjusted for T1D duration, sex, and age group).  Similarly, higher BMIz 
(WHO) was associated with increased frequency of at least one SH event in the past year, 
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adjusted for T1D duration, sex, age group, and registry (Figure 2b, p<0.001). However, when 
looking at registry-specific BMIz (CDC or KiGGS), higher BMIz was significantly associated 
with SH within DPV (p=0.004) but only marginally within T1DX (p=0.05). 
Discussion   
In contrast to historic experience, our data demonstrate that youth with T1D have elevated BMIz 
compared to the international norms developed by the WHO and the respective national norms 
for youth in the US and in Germany/Austria.  These data extend the findings of recent reports 
from the DCCT/EDIC study to highlight the consistency of elevated BMI in Western countries in 
which intensive management of T1D is standard of care (5).  Of particular concern, our cross-
sectional data also demonstrate that higher weight in youth with T1D may be inversely 
associated with achieving the goals of intensive treatment, since increased BMIz was associated 
with higher HbA1c in both registries.  This relationship between HbA1c and BMI was not found 
in a recent paper by Redondo et al, but that study assessed a cohort of newly diagnosed patients 
with T1D, whereas our report was limited to participants with at least 1 year T1D duration (mean 
duration 4.8±3.5 years) (28).  Increased BMIz was associated with a greater risk of SH in the 
DPV cohort, but an association between BMI and SH was not found in the T1DX registry.  
However, these differences in HbA1c and SH between BMI groups were small and may not be 
clinically relevant. Further, the cause-effect relationship of the association between SH and BMI 
is uncertain.  
 
When comparing to international WHO BMI standards, youth in the T1DX were more obese 
than youth in the DPV, except in the 2-<6 year old group.  It is likely that the differences in 
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lifestyle and nutrition that contribute to increased rates of obesity in non-diabetic children in the 
US compared to Europe also contribute to the different prevalence of overweight and obesity in 
youth with T1D.  Whether differences in nutritional counseling and carbohydrate counting 
recommendations for patients with T1D between US and Europe also contribute to these trans-
Atlantic differences in BMI remains to be determined.   
 
Healthy weight is an important component of care for youth with T1D but how to achieve this 
goal while maintaining glucose and HbA1c levels as close to normal as possible with intensive 
insulin therapy has not been established. Greater attention to avoidance of excessive caloric 
intake and better food choices early in the treatment of T1D, encouragement of regular physical 
activity, reduced screen time, and the elimination of unnecessary snacks are among the factors 
that could play roles in achieving and maintaining healthy weights in this population.  Given the 
challenges of preventing and treating obesity in youth with T1D who receive intensive treatment, 
adjunctive therapies to insulin, like metformin, GLP1 agonists and SGLT2 inhibitors that have 
been shown to lower HbA1c and body weight in adults with T2D, could be important additions 
to current options for care in youth with T1D (29, 30). 
 
Recent studies indicate that the benefits of limiting excessive weight gain in children and 
adolescents with T1D extend beyond improvements in body image and psychosocial well-being 
to include a reduction in insulin resistance and cardiovascular risk factors.  Insulin resistance is 
increased in youth with T1D compared to non-diabetic youth of similar age, sex, and BMIz, 
especially in children who fail to achieve target HbA1c levels (31, 32).  As insulin resistance 
increases so do cardiovascular disease risk factors (33).  Similarly, data from the DCCT/EDIC 
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study in adults with T1D indicate that excessive weight gain is associated with insulin resistance, 
hypertension, dyslipidemia, central obesity, and more extensive atherosclerosis (as assessed by 
coronary artery calcium and carotid intima media thickness) (5).  Further studies on the 
magnitude of the association of obesity with vascular disease risk factors in youth with T1D are 
needed (34). 
 
As with any comparison between two large clinical registries, differences in the data collection 
methods are a potential limitation.  SH events were clinic-reported for both registries; however, 
the type of data extraction—manual for T1DX and automatic for DPV—may have led to 
underreporting of events within T1DX.  For this report, while there may be some differences in 
the collection of height and weight measurements across the clinics, it is highly unlikely that all 
errors are in the same direction, thus reducing the possibility of systematic bias.  Additionally, 
standardized measurements of height and weight using calibrated devices and trained personnel 
is standard in pediatric endocrine /diabetes clinics taking care of children with T1D.  Regarding 
possible differences in HbA1c measurements, we have previously reported that in both registries 
HbA1c methods are DCCT standardized and three different sensitivity analyses did not change 
results in a comparison focused on between-registry HbA1c differences in children <6 years of 
age (19).  However, it is possible that assay variation may mask relationships with HbA1c.  As 
noted above, the very large sample sizes of the two registries may result in associations that are 
statistically significant but not clinically important.  It also should be noted that the reference 
tables used to calculate BMIz are somewhat outdated, particularly CDC data, which dates prior 
to 2000.  The KiGGS reference tables are also somewhat dated, as the normative data was 
collected from 2003-2006.  However, for the aim of comparing BMI between the registries, the 
Page 12 of 23 
 
potentially outdated reference tables are not a limitation.  Finally, the DPV registry is a 
population-based sample that included 70-90% of all potential patients in Germany and Austria 
whereas the T1DX registry is a sample of patients from participating pediatric diabetes centers 
staffed by pediatric endocrinologists and only includes the children of families who volunteered 
to participate.  The T1DX registry participants represent about one fourth of the patients with 
T1D who are followed at a T1D Exchange Clinic Network site (16), thus the T1DX data may not 
be representative of all youth with T1D in the US.  While it is difficult to compare 
socioeconomic status between the two registries, the proportion of minorities was similar for 
each group—21% of T1DX participants were not non-Hispanic white and 20% of DPV 
participants had a history of migration (defined as at least one parent born outside of Germany or 
Austria).  
 
In conclusion, the obesity epidemic has not spared youth with T1D, as youth in both the T1DX 
and DPV registries have elevated BMIz, with youth in the T1DX being more obese than those in 
DPV.  Increased obesity in youth with T1D has negative implications for glucose control, 
vascular disease risk factors, and future health outcomes.  Data from large registries such as the 
T1DX and the DPV allow for comparison of diabetes care and the opportunity to focus clinical 
care to improve outcomes for people with T1D.  An important future direction is to further delve 
into how practices differ between countries in an effort to discover which diabetes care strategies 
are most effective for youth with T1D.  
Acknowledgements:  
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Figure 1. Mean BMI Z-Score in T1DXvs. DPV by Age*  
 
Figure Legend 
Solid black bar= T1D Exchange 
Solid white bar= DPV 
Error bars show 95% CI. 
*Means and p values obtained from a mixed model comparing BMI z-score (WHO reference) 
between the two registries, adjusted for T1D duration, sex, age group, random site effect, and the 
interaction between registry and age group. BMI z-score of 0 is equivalent to the mean value of 
the WHO reference population.  
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Figure 2a. Mean HbA1c by BMI Category* 
 
Figure Legend 
Black bar= Mean HbA1c. Error bars show 95% CI. 
*P value obtained from a mixed model adjusted for T1D duration, sex, age group, registry, and 
random site effect, with BMI z-score as a continuous variable.  Means obtained from a mixed 
model adjusted for T1D duration, sex, age group, registry, and random site effect, with BMI as a 
categorical variable. Underweight individuals were excluded.  
Figure 2b. Percent with Severe Hypoglycemic Event in Past Year by BMI Category* 
 
Figure Legend 
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Black bar= Percent with ≥1 severe hypoglycemia event (seizure/loss of consciousness) in the 
past year. Error bars show 95% CI. 
*P value obtained from a mixed model adjusted for T1D duration, sex, age group, registry, and 
random site effect, with BMI z-score as a continuous variable. Means obtained from a mixed 
model adjusted for T1D duration, sex, age group, registry, and random site effect, with BMI as a 
categorical variable. Underweight individuals were excluded. 
Table 1. Participant Characteristics of T1DX and DPV 
 Overall 
N=32,936 
T1DX 
N=11,435 
DPV 
N=21,501 
Male - (%) 52% 51% 52% 
Age - median (25th, 75th percentile) 12.6 (9.5, 15.1) 12.8 (9.9, 15.3) 12.4 (9.2, 15.0) 
T1D Duration - median (25th, 75th percentile) 4.0 (1.9, 7.0) 4.0 (2.0, 7.0) 3.6 (1.4, 6.7) 
BMI Z-score (WHO) - median (25th, 75th 
percentile) 0.70 (0.07, 1.36) 0.78 (0.16, 1.47) 0.65 (0.02, 1.30) 
BMI Z-score (CDC and KiGGS) - median (25th, 
75th percentile) N/A 0.74 (0.18, 1.30) 0.33 (-0.24, 0.89) 
Insulin Pump Use - (%) 49% 56% 45% 
HbA1c (%) - mean±SD 
mmol/mol 
8.1±1.4% 
65.1±15.2 
8.5±1.4% 
68.9±15.1 
7.9±1.4% 
63.1±14.9 
Frequency of Self-Monitoring of Blood Glucose - 
median (25th, 75th percentile) 6 (5, 8) 6 (4, 7) 6 (5, 8) 
Total Daily Insulin Dose (units/kg body weight) - 
median (25th, 75th percentile) 0.82 (0.65, 1.02) 0.82 (0.64, 1.03) 0.82 (0.66, 1.02) 
Percent Prandial Insulin - median (25th, 75th 
percentile) 57% (48%, 65%) 56% (47%, 65%) 57% (48%, 65%) 
≥1 Severe Hypoglycemic Event∞ in Past 12 
Months - (%) 2.5% 2.4% 2.5% 
Data shown are unadjusted percentages, mean±SD, or median and inter-quartiles (25th, 75th percentile). 
∞Resulting in seizure/loss of consciousness 
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Table 2. BMI Categories* Overall and by Registry, according to each Reference Table  
 Overall  
 
N=32,936 
T1DX  
 
N=11,435 
DPV  
 
N=21,501 
WHO Reference    
     Underweight - N (%) 192 (<1%) 61 (<1%) 131 (<1%) 
     Normal weight - N (%)  20,942 (64%) 6,844 (60%) 14,098 (66%) 
     Overweight - N (%) 7,825 (24%) 2,791 (24%) 5,034 (23%) 
     Obese - N (%) 3,977 (12%) 1,739 (15%) 2,238 (10%) 
CDC Reference    
     Underweight - N (%) 317 (1%) 86 (<1%) 231 (1%) 
     Normal weight - N (%)  22,629 (69%) 7,228 (63%) 15,401 (72%) 
     Overweight - N (%) 6,599 (20%) 2,547 (22%) 4,052 (19%) 
     Obese - N (%) 3,391 (10%) 1,574 (14%) 1,817 (8%) 
KiGGS Reference    
     Underweight - N (%) 988 (3%) 311 (3%) 677 (3%) 
     Normal weight - N (%)  27,178 (83%) 9,142 (80%) 18,036 (84%) 
     Overweight - N (%) 3,507 (11%) 1,392 (12%) 2,115 (10%) 
     Obese - N (%) 1,263 (4%) 590 (5%) 673 (3%) 
*BMI categories defined as follows: 
WHO:  Underweight: Z-score < -1.881 (<3rd percentile) 
 Normal weight: -1.881 ≤ Z-score ≤ 1.036 (3rd-85th percentile) 
 Overweight: 1.036 < Z-score ≤ 1.881 (>85th-97th percentile) 
 Obesity: Z-score > 1.881 (>97th percentile) 
CDC:    Underweight: Z-score < -1.645 (<5th percentile)    
            Normal weight:  -1.645 ≤ Z-score < 1.036 (5th-<85th percentile)   
          Overweight:  1.036 ≤ Z-score < 1.645 (85th-<95th percentile)    
           Obesity: Z-score ≥ 1.645 (≥95th percentile) 
KIGGS: Underweight: Z-score < -1.282 (<10th percentile)   
               Normal weight: -1.282 ≤ Z-score ≤ 1.282 (10th-90th percentile)  
               Overweight: 1.282 < Z-score ≤ 1.881 (>90th-97th percentile) 
               Obesity: Z-score > 1.881 (>97th percentile) 
 
